Inspyr Therapeutics

(OTO:NSPXD)

Symbol has changed to a new ticker symbol

(NSPX)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Inspyr Therapeutics Inc is an early-stage, pre-revenue, pharmaceutical company which is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation. It is also used in non-malignant conditions where it is rapidly increased in response to inflammation, hypoxia, ischemia, or trauma.

Contact Information

Main Phone: +1 818 597-7552
Address: 31200 Via Colinas
Address 2: Suite 200
State: CA
City / Town: Westlake Village
Country: US
Postal Code: 91365

Issuer Information

Exchange: OTO
CEO: Craig A. Dionne
Employees: 1
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A